190618_Alex-Swarbrick_Garvan-Institute

Research into predictive biomarkers at Garvan has been recognised internationally with a significant funding boost.

International fellowship for Garvan breast cancer researcher

Paul Timpson and Marina Pajic at the Garvan Institute

Paul-Timpson-Marina-Pajic-Garvan-Institute

Garvan researchers will contribute to multi-institutional collaborations to overcome current challenges in cancer treatment.

Researchers unite for major national cancer projects

230828-Thomas-Cox_Jessica-Chitty_lowres_Garvan-Institute

Thomas Cox and Jessica Chitty at the Garvan Institute

230829-Thomas-Cox_Jessica-Chitty_Garvan-Institute

Early laboratory results in mice show the drug PXS-5505 increases survival when combined with chemotherapy in the treatment of pancreatic ductal adenocarcinomas.


Drug that targets scar-like tissue in tumours shows promise for aggressive pancreatic cancer

Clockwise from top left: Professor Joseph Powell, Professor Stuart Tangye, Dr Kishore Kumar and Dr Ira Deveson

Joseph-Powell-Stuart-Tangye-Kishore-Kumar-Ira-Deveson_Garvan-Institute

Four Garvan researchers will lead projects to harness genomics for improved diagnosis and treatment of disease.

Genomics Health Futures Mission funds medical research at Garvan

David Thomas at Project Prospect launch at Garvan

220317_David-Thomas-Project-Prospect_Garvan-Institute

The Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) will establish Australia as a medical manufacturing hub: building links from research through to the clinic; creating jobs; changing lives.

$185 million investment to fast-track treatments for rare and ‘untreatable’ cancers

ira-deveson-and-kishore-kumar_Garvan-Institute.jpeg

Garvan researchers have shown how new genomic sequencing technology can reduce the 'diagnostic odyssey' experienced by people with rare neurological and neuromuscular diseases.

Single test for over 50 genetic diseases will cut diagnosis from decades to days

Imaging showing cancer cells (green) being attacked by neutrophils (red) in the collagen structure (blue) of a tumour’s microenvironment. Credit: Jacqueline Bailey / Dr Chtanova's Innate and Tumour Immunology Lab at Garvan

230615_Cancer-cells-and-neutrophils-in-a-tumour-microenvironment-Credit-Jacqueline-Bailey_Garvan-Institute

Microbial therapy can activate neutrophils to destroy triple-negative breast cancer and other cancers.

Exposing cancers to bacteria reminds first responder immune cells which side they’re on

221118_Sean-Porazinski_Garvan-Institute

PanKind Foundation supports new study to develop tailored therapy for pancreatic cancer.

Accelerator Grant for pancreatic cancer researcher

Fluorescent imaging of retinal pigment epithelium. Credit: Dr Grace Lidgerwood

220726_Fluorescent-imaging-of-retinal-pigment-epithelium_Garvan-Institute

The discovery of molecular signatures of age-related macular degeneration will help with better diagnosis and treatment of this progressive eye disease.

Genetic clues to age-related macular degeneration revealed

Garvan_staircase-600x380.jpeg

The NHMRC has allocated $9 million to fund the critical research projects of five outstanding Garvan researchers.

Garvan researchers awarded five NHMRC Investigator Grants

Daniel-Christ-antibody-screen.jpeg

Key molecules involved in mammalian-meat anaphylaxis have had their structure revealed, paving the way for future treatments.

Genetic and molecular insights into dangerous tick bite-related meat allergy revealed

Joseph-Powell_new.png

Australian researchers uncover hidden genetic markers of glaucoma

Stem-cell models reveal glaucoma secrets

Deborah-Burnett.jpg

The 2023 NSW Premier’s Prize for Early Career Researcher of the Year (Biological Sciences) recognises Garvan’s Dr Deborah Burnett.

Dr Deborah Burnett honoured with NSW Premier’s Prize

Mandy-Ballinger-Garvan-Institute.jpg

In recognition of her work to improve lives for those with sarcoma, Dr Mandy Ballinger has received the Liddy Shriver Early Career Research Award.

Dr Mandy Ballinger honoured with international sarcoma award

Deborah_Burnett_Garvan_Institute

Prestigious fellowship recognises Dr Burnett’s exceptional research in immunology.

L’Oréal-UNESCO Fellowship awarded to Garvan’s Dr Deborah Burnett

221118_Amanda-Khoury_Garvan-Institute

Dr Amanda Khoury will take part in an acclaimed national program, becoming a role model for the next generation of scientists.

Garvan researcher announced as a Superstar of STEM

Liz-Caldon-Garvan-Institute

By analysing more than 80 clinical trials, researchers at Garvan have identified genetic tests that predict which cancer patients are likely to benefit from PARP inhibitors in combination with chemotherapy.

Predicting cancer patient response to PARP inhibitors

bone-imaging-Garvan-Institute

Imaging technology developed at Garvan shows that bone-resorbing osteoclasts gather in distinct pockets, leading to new insights for osteoporosis and cancer treatment.

Cutting-edge imaging sheds new light on cells that break down bone

New research reveals how zero-calorie sweeteners rewire the brain into feeling hungry.

Why artificial sweeteners can increase appetite

Peter_Croucher_Garvan_Institute

Professor Peter Croucher has been honoured with an award from the American Society for Bone and Mineral Research.

Prestigious bone research award for Professor Peter Croucher

Professor Stuart Tangye

Prestigious award recognises Professor Stuart Tangye’s international leadership in immunology.

Professor Stuart Tangye elected as Fellow of the Australian Academy of Health and Medical Sciences

Edmund-Hofflin-Garvan-Institute-low-res.jpg

Rebekah and her son Edmund went through a diagnostic odyssey to find the cause of Edmund's symptoms

Edmund-autoimmune-diagnosisGarvan-Institute

A bout of strep throat was the start of a diagnostic odyssey. The discovery of a rare genetic variant led to an effective therapy.


Edmund’s rare genetic variant uncovered a life-changing treatment

230609_Benjamin-Kile_Garvan-Institute

Benjamin_Kile_Garvan-Institute.png

Professor Benjamin Kile, internationally recognised blood cell molecular biologist, will lead Garvan as its next Executive Director.

Garvan appoints respected scientist and research leader as new Executive Director

Take 5000 people, scrutinise for three decades and what do you get? A wholly new understanding of osteoporosis for starters, and the insights keep on coming.

Dubbo Osteoporosis Epidemiology Study

Paspaley-Kinberley-Bracelet.jpeg

Paspaley recently released the 'Kimberley Bracelet' to support Garvan 's cancer research. 20% of the purchase price is donated to Garvan, with Paspaley customers choosing which area of cancer research to support.

Paspaley 's Kimberley Bracelet for cancer research

A Garvan scientist, in collaboration with colleagues from Switzerland, has demonstrated for the first time how an important class of immune cells, 'Follicular dendritic cells ', essential for the development of antibodies, comes into being. The significance of their finding is underlined by its publication in the very prestigious international journal Cell. 

Understanding how a key group of immune cells is born

Connie-Samual-Johnson-Garvan.jpeg

Vale Constance (Connie) Johnson OAM 1977 – 2017.

Vale Connie Johnson OAM

Pancreatic cancer cells activate the molecule AKT (blue) to multiply and spread along connective stroma (pink) in the cancer environment. Credit: Max Nobis (VIB-KU Leuven Center for Cancer Biology)


230428_Pancreatic-cancer-cells_Garvan-Institute

Image showing pancreatic cancer cells activating the molecule AKT (blue) to multiply and spread along connective stroma (pink) in the cancer environment. Credit: Max Nobis (VIB-KU Leuven Center for Cancer Biology)

Pancreatic cancer drug response and resistance has been uncovered in unprecedented detail, thanks to a research tool developed at the Garvan Institute.

Researchers image live drug response and resistant ‘pockets’ in pancreatic cancer

230904_Jodie-Ingles_lowres_Garvan-Institute

230904_Jodie-Ingles_Garvan-Institute

Researchers are recruiting anyone affected by sudden cardiac arrest to a study aimed at improving support for those at risk.


Study to identify early warning signs of sudden cardiac arrest

190315_Cancer-Council-NSW_Garvan-Institute

Dr Thomas Cox and Professor Chris Ormandy have been awarded three-year Project Grants from Cancer Council NSW to explore innovative research projects in pancreatic and breast cancer respectively.

Cancer Council NSW grants for innovative cancer research

David-Gallego-Ortega_Garvan-Institute.jpg

Targeting the tumour environment may help improve treatments for breast cancers affecting pregnant women and young mothers.

Inflammation a key to targeting pregnancy-associated breast cancer

The Australian Parkinson’s Mission, an innovative program combining clinical trials with genomics research for people with Parkinson’s, has received $30 million in Federal Government funding, the most significant investment in Australian Parkinson’s research.

Australian Parkinson’s Mission $30M funding boost

220421_Stuart-Tangye_Garvan-Institute

Identifying a rare genetic mutation that weakens the immune system can better inform those who may be at higher risk of severe viral illness.

Rare genetic mutation linked to risk of severe viral infection in Polynesian populations

Tri-Phan_Garvan-Institute.jpg

State-of-the-art genomics will drive research into how the immune system’s response to a common virus affects our risk of developing multiple sclerosis.

MRFF funds Garvan-led multiple sclerosis research

Researchers examine imaging in the ACRF INCITe Centre at the Garvan Institute of Medical Research

220630_ACRF-INCITe-Centre_Garvan-Institute

The new ACRF INCITe Centre provides world-leading microscope technology for unprecedented views of cancer and immune cell interactions, a game-changer for cancer research

ACRF INCITe Centre for world-class cancer imaging launches at the Garvan Institute

190708_Susan-Clark-and-Katherine-Samaras_Garvan-Institute

Garvan and CSIRO researchers have uncovered key differences underlying harmful and non-harmful fat.

Genomic ‘map’ reveals not all fat is equal

190712_Ozren-Bogdanovic-and-Ksenia-Skvortsova_Garvan-Institute

A study in zebrafish indicates that some genes linked to cancers in humans have been strictly regulated throughout evolution.

Ancient epigenetic changes silence cancer-linked genes

190717_DNA-molecule_Garvan-Institute

A new research method to pinpoint the immune cells that recognise cancer could significantly change how we treat the disease.

A genomic barcode tracker for immune cells

Katherine-Samaras_Garvan-Institue.jpeg

The Federal Government has awarded Professor Katherine Samaras a prestigious project grant to carry out critical dementia research.

Clinical trial to test diabetes treatment for dementia

190813_Claire-Vennin_Garvan-Institute

Targeting the tissue around pancreatic cancer cells may be the key to stopping their spread and improving chemotherapy outcomes.

Key to targeting the spread of pancreatic cancer

Jacqueline Center and Dana Bluic at the Garvan Institute

Jacqueline-Center-Dana-Bluic_Garvan-Institute.jpeg

A large cohort study has revealed a common osteoporosis drug significantly decreases premature mortality risk, likely related to a reduction in bone loss.

Osteoporosis drugs linked to reduced risk of premature death

190826_retina-atlas_Garvan-Institute

Australian researchers reveal new insights into retina’s genetic code

The NHMRC Investigator Grant Scheme will provide $8.5 million in funding to researchers at the Garvan Institute of Medical Research over the next five years, in recognition of their outstanding track records in research.

NHMRC Investigator Grants awarded to Garvan researchers

190918_David-Thomas-Maya-Kansara_Garvan-Institute

Research reveals a new therapeutic target for the treatment of osteosarcoma.

Psoriasis drug target offers potential for osteosarcoma

Chris Goodnow, Shane Grey & Nathan Zammit

190919_Chris-Goodnow-Shane-Grey-Nathan-Zammit_Garvan-Institute

Garvan researchers have discovered a gene variant that sheds new light on how human immunity was fine-tuned through history.

Extinct human species gave modern humans an immunity boost

191018_Sean-ODonoghue_Garvan-Institute

A step-by-step roadmap reveals the complex biological process of how cells copy their DNA.

The big picture of a microscopic event

191029_Eva-Chan-Vanessa-Hayes_Garvan-Institute

A landmark study pinpoints the birthplace of modern humans in southern Africa and suggests how past climate shifts drove their first migration.

The homeland of modern humans

191030_Susan-Clark_Garvan-Institute

Professor Susan Clark FAA, has been awarded the 2019 NSW Premier’s Prize for Excellence in Medical Biological Sciences.

NSW Premier’s Prize honours epigenetics expert

blue screen showing genomic information with a researcher pointing

191108_research_Garvan-Institute

Researchers from across the Institute have been awarded seven grants from the St Vincent’s Clinic Foundation.

St Vincent’s Clinic Foundation Grants for Garvan researchers

191119_Samantha-Oakes-Lesley-Castillo_Garvan-Institute

A potential treatment for pancreatic cancer shows promise in mice, reducing cancer spread by more than 60%.

Combination treatment shows promise for pancreatic cancer

Over six years, researchers evaluated the cognitive effects of statins in elderly consumers, revealing no negative impact and potential protective effects in those at risk of dementia.

Research reveals no link between statins and memory loss

191125_Kate-Patterson_Garvan-Institute

Virtual reality experience developed by a Garvan-led team allows users to explore the life inside a cell.

Genomics education steps into virtual reality in ‘Cell Explorer’

Simon Oaten, Omid Faridani, Julie Godfrey & Jenny Grainger

191129_Simon-Oaten-Omid-Faridani-Julie-Godfrey-Jenny-Grainger_Garvan-Institute

Garvan’s Dr Omid Faridani has received the 2019 Pathfinders Award for his work developing a device that may personalise pancreatic cancer treatment.

New path forward for pancreatic cancer treatment

190624_Tri-Phan-Cindy-Ma_Garvan-Institute

A team of researchers and medical professionals are looking to answers in DNA to improve the lives of patients with rare immune conditions.

CIRCA solves rare disease mysteries by combining expertise

Researchers are set to take the closest look at breast cancer yet to identify better ways of targeting the disease.

Garvan researchers to create an ‘Atlas’ for breast cancer

Garvan Neuroscience PhD student Ira Deveson, a member of Prof John Mattick’s RNA Biology and Plasticity lab, won the 2014 St Vincent’s Precinct Three Minute Thesis Competition on 12 June.

2014 St Vincent's Precinct Three Minute Thesis Competition

Ten PhD Students from across the St Vincent's Precinct have taken part in the annual Three Minute Thesis competition.

2019 St Vincent’s Precinct Three Minute Thesis competition

researcher_awards.jpeg

Congratulations to the seven researchers who were presented with awards or prizes at the 2019 Garvan Researcher Awards event.

The 2019 Garvan Researcher Awards

190611_Ted-Kraegen_Garvan-Institute

Emeritus Professor Edward (Ted) Kraegen AO has been recognised in the 2019 Queen’s Birthday Honours.

Queen’s Birthday Honours for Garvan’s Prof Ted Kraegen

Abhinav Humar, Jon Sprent and Fadi Lakkis

190522_Abhinav-Humar--Jon-Sprent-and-Fadi-Lakkis_Garvan-Institute

Professor Jonathan Sprent has accepted the 2018 Thomas E. Starzl Prize in Surgery & Immunology at an award ceremony at the University of Pittsburgh.

Professor Jonathan Sprent awarded prestigious Starzl Prize

190517_Mana-Liao_Garvan-Institute

Dr Mana Liao has been invited to help find solutions to the big questions facing the future of biotechnology.

Garvan Innovation Manager selected as ‘Leader of Tomorrow’

Venessa-Chin_Garvan-Institute.jpg

Garvan’s Dr Venessa Chin has received a two-year Lung Foundation fellowship to undertake research to change the management of lung cancer.

Dr Venessa Chin receives Lung Foundation fellowship

Professor-Steve-Wesselingh-and-Professor-Stuart-Tangye_Garvan-Institute.jpg

Professor Stuart Tangye has been awarded the 2019 NHMRC Peter Doherty Investigator Grant Award.

Research excellence acknowledged for Professor Stuart Tangye

Michelle-McDonald-Alex_Swarbrick-Joanna-Achinger-Kawecka-and-Omid_Faridani.jpg

Four Garvan scientists will pioneer world-leading research on breast, pancreatic and bone cancer, thanks to funding from Cancer Council NSW.

Explore our research

Our impact

Our people

News and resources

About us

Support Us

News

Featured Article

Predicting cancer patient response to PARP inhibitors